Skip to main content
. 2020 Feb 12;8:2. doi: 10.3389/fpubh.2020.00002

Table 6.

Symptoms reported by enrolled Associates by age (adult = age ≥ 18 years, child = age ≤ 18 years), among those with symptomatic infections (defined as the presence of any solicited symptom) in Ecuador.

Ecuador
Total—by age Total—by serology* Primary Secondary
Child Adult p-value 1o 2o p-value Child Adult p-value Child Adult p-value
# Dengue illnesses** 27 67 NA 42 45 NA 13 29 8 37
Asymptomatic 34.2% 32.9% 0.889 42.9% 22.2% 0.040 53.8% 37.9% 0.501 25.0% 21.6% 1.000
Hospitalized 0% 0% NA 0% 0% NA 0% 0% NA
Fever 22.9% 14.1% 0.282 9.8% 20.0% 0.235 8.3% 10.3% 1.000 25.0% 18.9% 0.651
Headache 33.3% 27.8% 0.660 19.5% 37.8% 0.095 16.7% 20.7% 1.000 25.0% 40.5% 0.690
Rhinorrhea N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Cough N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Nausea/vomiting 13.2% 7.6% 0.333 4.8% 8.9% 0.677 0.0% 6.9% 1.000 0.0% 10.8% 1.000
Drowsiness 16.7% 21.5% 0.623 14.6% 26.7% 0.195 8.3% 17.2% 0.651 12.5% 29.7% 0.419
Muscle/joint pain 11.1% 34.2% 0.012 31.7% 33.3% 1.000 25.0% 34.5% 0.719 12.5% 37.8% 0.236
Abdominal pain 13.9% 22.8% 0.323 17.1% 26.7% 0.311 8.3% 20.7% 0.651 25.0% 27.0% 1.000
Rash 22.2% 7.6% 0.034 14.6% 13.3% 1.000 33.3% 6.9% 0.050 25.0% 10.8% 0.286
Diarrhea 2.8% 11.4% 0.168 4.9% 15.6% 0.161 0.0% 6.9% 1.000 0.0% 18.9% 0.321
Retroorbital pain 13.9% 26.6% 0.155 17.1% 35.6% 0.087 16.7% 17.2% 1.000 25.0% 37.8% 0.691
Bleeding 0.0% 1.3% 1.000 2.4% 0.0% 0.477 0.0% 3.4% 1.000 0.0% 0.0% NA
*

Of those with valid serological results (i.e., either primary or secondary DENV infection).

**

Among all those with confirmed DENV infection (i.e., whether symptomatic or asymptomatic).

P-values < 0.05 indicate statistically significant comparisons, applying Mantel-Haenszel chi-squared testing.

NA indicates not applicable.